O
Ogenix develops and provides EPIFLO oxygen therapy as an adjunct treatment for wound healing. This system delivers oxygen to support the healing process for patients and is applicable in various clinical settings. The company offers resources and protocols for clinicians and patients to integrate EPIFLO into existing wound care regimens.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ogenix develops and provides EPIFLO oxygen therapy as an adjunct treatment for wound healing. This system delivers oxygen to support the healing process for patients and is applicable in various clinical settings. The company offers resources and protocols for clinicians and patients to integrate EPIFLO into existing wound care regimens.